Stock Information
Natera Inc (NTRA)
Ticker Symbol: NTRA
Exchange: NASDAQ
Sector: Biotechnology
Market Cap: $37,949.96 mil
Piotroski score: 3
PE Ratio: N/A
EPS (TTM): -1.3652
Revenue (TTM): $18.89 M
Dividend Yield: N/A%
ROE: -11.73%
Latest News
-
Citigroup Maintains Buy on Natera, Raises Price Target to $365
Thu, Aug 13, 2026 3:50 PM
-
Natera, Inc. (NTRA) Presents at Canaccord Genuity's 46th Annual Growth Conference Transcript
Thu, Aug 13, 2026 10:27 AM
-
Piper Sandler Maintains Overweight on Natera, Raises Price Target to $363.5
Wed, Aug 12, 2026 12:26 PM
-
Stephens & Co. Maintains Overweight on Natera, Raises Price Target to $350
Wed, Aug 12, 2026 12:20 PM
-
Guggenheim Maintains Buy on Natera, Raises Price Target to $360
Wed, Aug 12, 2026 8:18 AM
-
Natera Announces New Collaboration Regarding Phase 1 Clinical Trial, Sponsored By Kupando Therapeutics
Wed, Aug 12, 2026 6:04 AM
-
Guardant Health: Screening And MRD Are Just Getting Started
Tue, Aug 11, 2026 2:59 PM
Key Financials
Financial data not available
